Prevention and Control of Tick-Borne Diseases: Vaccine Development and Implementation
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Epidemiology".
Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 4929
Special Issue Editors
Interests: central nervous system infections; tick-borne diseases; parasitic diseases
Special Issues, Collections and Topics in MDPI journals
Interests: tick-borne diseases; meningitis; encephalitis; respiratory pathogens
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Ticks transmit a number of microorganisms to both pets and humans. At this point, it is worth mentioning at least some that attract public attention: Borrelia species bacteria, tick-borne encephalitis virus, and Babesia parasites. Diseases caused by these pathogens are emerging in new territories in many parts of the world.
Safe and effective vaccines have been licensed for tick-borne encephalitis (TBE), while Lyme borreliosis is not yet a vaccine-preventable disease. New vaccine development is an important public health issue.
The results of numerous research projects have recently been published. Topics include current Lyme disease vaccine progress, TBE vaccination breakthrough cases, molecular aspects of TBE vaccines with relation to other Flavivirus genus vaccines, and more.
This Special Issue is dedicated to diseases that are transmitted by tick bite. Submissions could include such topics as molecular aspects of vaccine development, the immunogenicity and efficacy of vaccines, immune responses to vaccines, coverage and safety issues, etc.
We look forward to receiving your valuable contributions!
Prof. Dr. Artur Sulik
Dr. Kacper Toczylowski
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tick-borne diseases
- tick-borne encephalitis
- Lyme disease
- ticks
- vaccine safety
- viral vaccine
- immunization
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.